The biggest case of fraud in biotech history is getting its day in the spotlight.
The agency is considering various strategies to get pricing under control. But do these ideas factor in critical drug pricing trends?
Last year, the FDA once again set a new record for new drug approvals and far surpassed its 10-year average.
From new tech to innovative business models and shifting regulations, industry experts weigh in on what changes are coming down the pipeline.